NCT00395486View on ClinicalTrials.gov

ROMEO (Rosuvastatin in Metabolic syndrOme)

PHASE4CompletedINTERVENTIONAL
Enrollment

258

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Metabolic Syndrome X
Interventions
DRUG

Rosuvastatin

10mg

DRUG

Atorvastatin

10mg

Trial Locations (3)

Unknown

Research Site, Pusan

Research Site, Seoul

Research Site, Suwon

Sponsors

Lead Sponsor

AstraZeneca
All Listed Sponsors
lead

AstraZeneca

INDUSTRY

NCT00395486 - ROMEO (Rosuvastatin in Metabolic syndrOme) | Biotech Hunter | Biotech Hunter